- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, April 21, 2023
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by CVS Health referenced a study published in the February 2022 issue of The American Journal of Managed Care® (AJMC®). The study, “Value-Based Care Through Postacute Home Health Under CMS PACT Regulations,” found that home health was associated with reduced 30-day readmissions and costs vs no postacute care. The study was also cited in a piece by Home Health Care News covering CVS Health’s article.
An article by Drug Topics® referenced the biosimilar approval tracker on the Center for Biosimilars® website, which lists how many biosimilars have been approved and their product launches worldwide. The Center for Biosimilars is a sister site of AJMC.com, the website of AJMC; Drug Topics is also a publication of MJH Life Sciences®, the publisher of AJMC.
The Breakdown: Breast Cancer Research Awareness Day
August 19th 2025Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American Journal of Managed Care® breaks down the most recent advancements in breast cancer prevention, screening, and therapies.
Listen
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Oral GC Dose Tapering for MG Linked to Efgartigimod Initiation
August 25th 2025Using US claims data, the authors evaluated oral glucocorticoid (GC) use at 5 time points during their retrospective analysis: 3 months before starting efgartigimod and 3, 6, 9, and 12 months after starting efgartigimod.
Read More
